Journals / Turkish Journal of Anaesthesiology and Reanimation / 2015 / Cilt: 43 - Sayı: 4

Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis

Sistemik Eritematosuslu Hastada Gelişen Posterior Reversibl Ensefalopati Sendromunun Tedavisinde Plazmaferez

Pages
291–294
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To control the hy- pertension, plasmapheresis should be kept in mind in addition to the multiple antihypertensive therapy in these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy syndrome is characterized by visual and mental disturbances, nausea and vomiting and gener- alized or focal convulsions and often represents itself with parietal and occipital oedema formation.
📊
Key Findings & Data:We want to report the treatment of posterior reversible encephalopathy syndrome with plasmapher- esis, which developed in a 35-year-old woman with systemic lupus erythematosus diagnosed by renal biopsy 3 years ago.
💡
Conclusion & Impact:To control the hy- pertension, plasmapheresis should be kept in mind in addition to the multiple antihypertensive therapy in these patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Posterior reversible encephalopathy syndrome is characterized by visual and mental disturbances, nausea and vomiting and gener- alized or focal convulsions and often represents itself with parietal and occipital oedema formation. We want to report the treatment of posterior reversible encephalopathy syndrome with plasmapher- esis, which developed in a 35-year-old woman with systemic lupus erythematosus diagnosed by renal biopsy 3 years ago. She has been followed up in the intensive care unit three times. However, she had been transferred to the nephrology department of our uni- versity hospital because of her uncontrolled blood pressure. Oral antihypertensive therapy, corticosteroid 500 mg 1 × 1 and cyclo- phosphamide were started for the activation of lupus. After the detection of low complement levels, systemic lupus erythematosus activation was suspected. She developed mental deterioration af- ter her first plasmapheresis treatment and was then consulted by the neurology and intensive care unit doctors. Diffusion cranial magnetic resonance imaging was found compatible with posterior reversible encephalopathy syndrome. The patient was transferred to our intensive care unit. The patient gained consciousness after her second plasmapheresis. After 5 days of follow-up in our inten- sive care unit and after significant regression was observed in the magnetic resonance imaging analysis, the patient was transferred to the nephrology service conscious, cooperated and orientated. At the nephrology service, after a total of 13 times of plasmapheresis, complement levels were increased and she was discharged with cor- ticosteroid therapy. Posterior reversible encephalopathy syndrome can be observed in patients with systemic lupus erythematosus and intensive care unit treatment may be required. To control the hy- pertension, plasmapheresis should be kept in mind in addition to the multiple antihypertensive therapy in these patients.

Özet

Posterior reversible ensefalopati sendromu, bulantı-kusma, görsel ve mental değişiklikler, jeneralize veya fokal nöbetler ile karakteri- ze olan ve genellikle kendini pariyetal ve oksipital bölgede yaygın ödem formasyonu ile kendini gösterir. Otuz beş yaşında 3 yıl önce böbrek biyopsisi ile sistemik lupus eritematozus tanısı konulan kadın hastada gelişen posterior reversibl ensefalpati olgusunun plazmaferezle tedavisini rapor etmek istedik. Hasta 3 kez yoğun bakımda takip edilmişti. Ancak kontrolsüz kan basıncı nedeniyle üniversitemiz nefroloji servisine sevk edilmişti. Hastaya lupus ak- tivasyonuna yönelik antihipertansif tedavi, kortikosteroid 1 x 500 mg ve siklofosfamid başlandı. Hastanın kompleman düzeylerinin düşük tespit edilmesi üzerine lupus aktivasyonundan şüphelenil- di. İlk plazmaferez tedavisi sonrası bilinci bozulan hasta nöroloji ve yoğun bakım doktorları tarafından konsülte edildi. Diffüzyon kraniyal manyetik rezonans görüntülemesi, posterior reversibl ensefalopati ile uyumlu bulundu. Hasta yoğun bakım ünitesi- ne transfer edildi. Hastanın ikinci plazmaferezden sonra bilinci açıldı. Hasta 5 gün yoğun bakım ünitemizde takip edildikten ve kontrol manyetik rezonans görüntülemesinde de belirgin gerileme gözlendikten sonra nefroloji servisine bilinç açık, oryente, koopere olarak devredildi. Nefroloji servisinde de toplam 13 kez plazma- ferez sonrası kompleman seviyeleri yükseldi ve kortikosteroid ile taburcu edildi. Sistemik lupus eritematozus hastalarında posterior reversibl ensefalopati görülebilmekte ve yoğun bakımda takip ge- rektirmektedir. Bu gibi hastalarda hipertansiyonun kontrolünde çoklu antihipertansif tedaviye ek olarak plazmaferez seçeneği de akılda tutulmalıdır.

🔖

Cite This Article

AYDIN, Z. İ. A., TURNA, C. K., ÖZERDEM, Ç. Y., YAVUZ, S., BAYKARA, N., SOLAK, M. (2015). Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 43 - Sayı: 4, 291–294. https://ajindex.com/articles/370332

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clinic Proc 2010; 85: 427-32. [CrossRef] 2. Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol 2011; 31: 202-15. [CrossRef] 3. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A, Tieulié N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008; 17: 139-47. [CrossRef] 4. Zhang YX, Liu JR, Ding MP, Huang J, Zhang M, Jansen O, et al. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med 2008; 47: 867-75. [CrossRef] 5. Thipisuttikul I, Phanthumchinda K. Reccurent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005; 252: 230-1. [CrossRef] 6. Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992; 19: 47-52. 7. West CD. Relative value of serum C3 and C4 levels in predicting relapse in systemic lupus erythematosus. Am J Kidney Dis 1991; 18: 686-8. [CrossRef] 8. Sanna G, Bertolaccini ML, Khamashta MA. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. Curr Pharm Des 2008; 14: 1261-9. [CrossRef] 9. Keskin HL, Uyanık G, Sivaslıoğlu AA, Çelen E, Avşar AF. Şiddetli preeklampsi olgusunda postpartum posterior reversibl ensefalopati sendromu. Türkiye Klinikleri J Gynecol Obst 2014; 24: 62-6. 10. Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH, et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004; 46: 978-83. [CrossRef]